JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cemerikic, B.
Right arrow Articles by Ahmed, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cemerikic, B.
Right arrow Articles by Ahmed, M. S.

Opioid tolerance in human placenta due to in vitro methadone administration

B Cemerikic, R Zamah and MS Ahmed

Department of Obstetrics and Gynecology, School of Medicine, University of Missouri-Kansas City, USA.

Explant culture of term placental villus trophoblast was investigated for its possible use as a model system for study of the effects of chronic methadone administration on binding and functional properties of placental kappa receptors. Viability parameters demonstrated that functional integrity of the tissue and its responsiveness to the modulation of human chorionic gonadotropin release by opioids are fully preserved during the 3 days of culture. Methadone administration for 2 days did not affect the viability of cultured explants. However, it resulted in the development of opioid tolerance, as demonstrated by a shift to the right in the concentration-response curve of U-69,593- induced stimulation of human chorionic gonadotropin release, and irresponsiveness to the inhibitory action of the antagonist nor- binaltorphimine. Kappa receptors of methadone-treated explants exhibited changes in their binding properties that preceded the shift in responsiveness. These data suggest that the development of tolerance to opioids in human placenta starts with an apparent down regulation and change in the affinity of the receptors and may involve downstream events that transduce receptor activation into a biological response.

Volume 273, Issue 3, pp. 987-994, 06/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.